Orbit International Corp. Reports 2022 Year End Results; Commences Process Toward Reinstatement Onto OTC Pink Market

Orbit International Corp.
Orbit International Corp.

In This Article:

2022 Net Income of $481,000 ($0.14 per diluted share) v. Net Income of $3,246,000 ($0.93 per diluted share) in Prior Year Period. Prior Period Includes $1,618,000 ($0.47 per diluted share) of PPP Loan Forgiveness. Exclusive of PPP Loan Forgiveness, Prior Period Net Income was $1,628,000 ($0.47 per diluted share)

2022 EBITDA, As Adjusted, was $412,000 ($0.12 per diluted share) v. $3,499,000 ($1.01 per diluted share) in Prior Year Period. Exclusive of PPP Loan Forgiveness, Prior Period EBITDA, As Adjusted was $1,881,000 ($0.54 per diluted share)

Fourth Quarter 2022 Net Income of $730,000 ($0.22 per diluted share) v. Net Income of $204,000 ($0.06 per diluted share) in Prior Year Period

Fourth Quarter 2022 EBITDA, As Adjusted, was $475,000 ($0.14 per diluted share) v. $244,000 ($0.07 per diluted share) in Prior Year Period

Backlog at December 31, 2022 was $19.4 million compared to $17.8 million at December 31, 2021 (inclusive of the backlog of SPS)

HAUPPAUGE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Orbit International Corp. (OTC Expert Market:ORBT) today announced results for the fourth quarter and the year ended December 31, 2022.

Results for the current quarterly and annual periods include the results of Simulator Product Solutions LLC (“SPS”). Prior year quarterly and annual periods do not include SPS’ results.

Fourth Quarter 2022 vs. Fourth Quarter 2021

  • Net sales were $7,462,000, as compared to $4,956,000.

  • Gross margin was 37.0%, as compared to 39.9%.

  • Net Income was $730,000 ($0.22 per diluted share), as compared to net income of $204,000 ($0.06 per diluted share).

  • Earnings before interest, taxes, depreciation and amortization, fair value adjustment on contingent liabilities and other non-current liability, and stock-based compensation (EBITDA, as adjusted) was $475,000 ($0.14 per diluted share), as compared to $244,000 ($0.07 per diluted share).

Full Year 2022 vs. Full Year 2021

  • Net sales were $26,074,000, as compared to $22,217,000.

  • Gross margin was 33.8%, as compared to 36.8%.

  • Net Income was $481,000 ($0.14 per diluted share), as compared to net income of $3,246,000 ($0.93 per diluted share). Net Income for the prior year period includes PPP loan forgiveness of $1,618,000 ($0.47 per diluted share). Exclusive of the PPP loan forgiveness, net income for the prior year was $1,628,000 ($0.47 per diluted share).

  • Earnings before interest, taxes, depreciation and amortization, fair value adjustment on contingent liabilities and other non-current liability, and stock-based compensation (EBITDA, as adjusted) was $412,000 ($0.12 per diluted share), as compared to $3,499,000 ($1.01 per diluted share). Prior year EBITDA, as adjusted, includes $1,618,000 ($0.47 per diluted share) of PPP loan forgiveness. Exclusive of the PPP loan forgiveness, EBITDA, as adjusted, was $1,881,000 ($0.54 per diluted share).

  • Backlog at December 31, 2022 was $19.4 million compared to $16.6 million at September 30, 2022 and $17.8 million at December 31, 2021 (inclusive of the backlog of SPS).